Format
Sort by
Items per page

Send to

Choose Destination

Best matches for chloroquine and covid-19:

Of chloroquine and COVID-19. Touret F et al. Antiviral Res. (2020)

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. Cortegiani A et al. J Crit Care. (2020)

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Wang M et al. Cell Res. (2020)

Search results

Items: 1 to 20 of 49

1.

Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes.

Monteiro WM, Brito-Sousa JD, Baía-da-Silva D, Melo GC, Siqueira AM, Val F, Daniel-Ribeiro CT, Guimarães Lacerda MV.

Rev Soc Bras Med Trop. 2020 Apr 6;53:e20200155. doi: 10.1590/0037-8682-0155-2020. eCollection 2020. No abstract available.

PMID:
32267301
2.

Chloroquine for COVID-19 Infection.

Moore N.

Drug Saf. 2020 Apr 7. doi: 10.1007/s40264-020-00933-4. [Epub ahead of print] No abstract available.

PMID:
32266694
3.

Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review.

Gbinigie K, Frie K.

BJGP Open. 2020 Apr 7. pii: bjgpopen20X101069. doi: 10.3399/bjgpopen20X101069. [Epub ahead of print]

PMID:
32265182
4.

Clinical trials on drug repositioning for COVID-19 treatment.

Rosa SGV, Santos WC.

Rev Panam Salud Publica. 2020 Mar 20;44:e40. doi: 10.26633/RPSP.2020.40. eCollection 2020.

PMID:
32256547
5.

Structural and molecular modeling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection.

Fantini J, Scala CD, Chahinian H, Yahi N.

Int J Antimicrob Agents. 2020 Apr 3:105960. doi: 10.1016/j.ijantimicag.2020.105960. [Epub ahead of print]

PMID:
32251731
6.

COVID-19 and Chloroquine/Hydroxychloroquine: is there Ophthalmological Concern?

Marmor MF.

Am J Ophthalmol. 2020 Mar 25. pii: S0002-9394(20)30132-X. doi: 10.1016/j.ajo.2020.03.028. [Epub ahead of print] No abstract available.

PMID:
32247518
7.

A Call for Randomized Controlled Trials to Test the Efficacy of Chloroquine and Hydroxychloroquine as Therapeutics against Novel Coronavirus Disease (COVID-19).

Keshtkar-Jahromi M, Bavari S.

Am J Trop Med Hyg. 2020 Apr 3. doi: 10.4269/ajtmh.20-0230. [Epub ahead of print]

PMID:
32247318
9.

Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries.

Singh AK, Singh A, Shaikh A, Singh R, Misra A.

Diabetes Metab Syndr. 2020 Mar 26;14(3):241-246. doi: 10.1016/j.dsx.2020.03.011. [Epub ahead of print]

10.

Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.

Xie M, Chen Q.

Int J Infect Dis. 2020 Apr 1. pii: S1201-9712(20)30204-6. doi: 10.1016/j.ijid.2020.03.071. [Epub ahead of print] Review.

11.

Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection.

Du YX, Chen XP.

Clin Pharmacol Ther. 2020 Apr 4. doi: 10.1002/cpt.1844. [Epub ahead of print] Review.

PMID:
32246834
12.

Potential therapeutic agents against COVID-19: What we know so far.

Lu CC, Chen MY, Chang YL.

J Chin Med Assoc. 2020 Apr 1. doi: 10.1097/JCMA.0000000000000318. [Epub ahead of print]

PMID:
32243270
13.

Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic.

Scuccimarri R, Sutton E, Fitzcharles MA.

J Rheumatol. 2020 Apr 2. pii: jrheum.200369. doi: 10.3899/jrheum.200369. [Epub ahead of print]

14.

Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.

Mégarbane B.

Clin Toxicol (Phila). 2020 Apr 2:1-2. doi: 10.1080/15563650.2020.1748194. [Epub ahead of print] No abstract available.

PMID:
32237918
15.

Treating COVID-19 with Chloroquine.

Huang M, Tang T, Pang P, Li M, Ma R, Lu J, Shu J, You Y, Chen B, Liang J, Hong Z, Chen H, Kong L, Qin D, Pei D, Xia J, Jiang S, Shan H.

J Mol Cell Biol. 2020 Apr 1. pii: mjaa014. doi: 10.1093/jmcb/mjaa014. [Epub ahead of print] No abstract available.

PMID:
32236562
16.

Combating COVID-19 with Chloroquine.

Hong W.

J Mol Cell Biol. 2020 Apr 1. pii: mjaa015. doi: 10.1093/jmcb/mjaa015. [Epub ahead of print] No abstract available.

PMID:
32236561
17.

The epidemiology, diagnosis and treatment of COVID-19.

Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y.

Int J Antimicrob Agents. 2020 Mar 28:105955. doi: 10.1016/j.ijantimicag.2020.105955. [Epub ahead of print]

PMID:
32234468
18.

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

Yazdany J, Kim AHJ.

Ann Intern Med. 2020 Mar 31. doi: 10.7326/M20-1334. [Epub ahead of print] No abstract available.

PMID:
32232419
19.

Chloroquine in COVID-19: the evidence.

Gupta N, Agrawal S, Ish P.

Monaldi Arch Chest Dis. 2020 Mar 31;90(1). doi: 10.4081/monaldi.2020.1290.

20.

Emerging prophylaxis strategies against COVID-19.

Agrawal S, Goel AD, Gupta N.

Monaldi Arch Chest Dis. 2020 Mar 30;90(1). doi: 10.4081/monaldi.2020.1289. Review.

Supplemental Content

Loading ...
Support Center